Company Filing History:
Years Active: 2023
Title: Christian Meyners: Innovator in HDAC Inhibitors
Introduction
Christian Meyners is a notable inventor based in Darmstadt, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of selective HDAC8 inhibitors. His work focuses on small molecule compounds that have the potential to treat various diseases, including cancer.
Latest Patents
Meyners holds a patent for "Selective HDAC8 inhibitors and their uses." This invention relates to small molecule compounds based on benzopyrimido- or benzoimidazo-thiazin-imine, along with their synthesis intermediates. The compounds are designed to act as HDAC inhibitors, specifically targeting HDAC8. The patent also discusses the application of these compounds in treating cancer and as therapeutic agents for eukaryotic parasites.
Career Highlights
Christian Meyners is affiliated with Hochschule Darmstadt, where he continues to advance his research in the field of pharmacology. His innovative work has led to the development of a patent that showcases his expertise and commitment to improving therapeutic options for patients.
Collaborations
Meyners collaborates with esteemed colleagues, including Franz-Josef Meyer-Almes and Alexander Kleinschek. Their combined efforts contribute to the advancement of research in HDAC inhibitors and their applications.
Conclusion
Christian Meyners is a pioneering inventor whose work on selective HDAC8 inhibitors holds promise for the treatment of cancer and other diseases. His contributions to medicinal chemistry are noteworthy and reflect his dedication to innovation in the field.